ARTICLES
Secondary acute myeloid leukemia following treatment with epipodophyllotoxins
SB Murphy
JCO Feb 1 1993: 199–201. [PDF]
What's the deal with follicular lymphomas?
DL Longo
JCO Feb 1 1993: 202–208. [PDF]
	Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide
	NJ Winick, RW McKenna, JJ Shuster, NR Schneider, MJ Borowitz, WP Bowman, D Jacaruso, BA Kamen, and GR Buchanan
	JCO Feb 1 1993: 209–217. [Abstract] [PDF]
	Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group
	JR Anderson, JM Vose, PJ Bierman, DD Weisenberger, WG Sanger, J Pierson, M Bast, and JO Armitage
	JCO Feb 1 1993: 218–224. [Abstract] [PDF]
	Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols
	S Bodis, M Henry-Amar, J Bosq, JM Burgers, WA Mellink, PY Dietrich, N Dupouy, EM Noordijk, JM Raemaekers, and J Thomas
	JCO Feb 1 1993: 225–232. [Abstract] [PDF]
	Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results
	JP Jacobs, KJ Murray, CJ Schultz, JF Wilson, MS Goswitz, CW Stevens, and JD Cox
	JCO Feb 1 1993: 233–238. [Abstract] [PDF]
	Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas [published erratum appears in J Clin Oncol 1993 May;11(5):1007]
	RM Pryzant, ML Meistrich, G Wilson, B Brown, and P McLaughlin
	JCO Feb 1 1993: 239–247. [Abstract] [PDF]
	AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B study
	BA Parker, M Santarelli, MR Green, JR Anderson, MR Cooper, D Case, Jr, M Barcos, BA Peterson, and AJ Gottlieb
	JCO Feb 1 1993: 248–254. [Abstract] [PDF]
	Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age
	JF Abrahamsen, A Andersen, E Hannisdal, O Nome, AF Abrahamsen, S Kvaloy, and H Host
	JCO Feb 1 1993: 255–261. [Abstract] [PDF]
	Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee
	R Heyn, V Haeberlen, WA Newton, AH Ragab, RB Raney, M Tefft, M Wharam, LG Ensign, and HM Maurer
	JCO Feb 1 1993: 262–270. [Abstract] [PDF]
	Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study
	NJ Winick, SD Smith, J Shuster, S Lauer, MD Wharam, V Land, G Buchanan, and G Rivera
	JCO Feb 1 1993: 271–278. [Abstract] [PDF]
	Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87
	U Creutzig, J Ritter, M Zimmermann, and G Schellong
	JCO Feb 1 1993: 279–286. [Abstract] [PDF]
	Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients
	JH Rodman, WL Furman, M Sunderland, G Rivera, and WE Evans
	JCO Feb 1 1993: 287–293. [Abstract] [PDF]
	Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias
	MA Schwartz, DR Lovett, A Redner, RD Finn, MC Graham, CR Divgi, L Dantis, TS Gee, M Andreeff, and LJ Old
	JCO Feb 1 1993: 294–303. [Abstract] [PDF]
	Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation- containing regimens
	JP Radich, JE Sanders, CD Buckner, PJ Martin, FB Petersen, W Bensinger, GB McDonald, M Mori, G Schoch, and JA Hansen
	JCO Feb 1 1993: 304–313. [Abstract] [PDF]
	Autologous bone marrow transplant in acute myeloid leukemia in first remission
	PA Cassileth, J Andersen, HM Lazarus, OM Colvin, JM Bennett, EA Stadtmauer, H Kaizer, RS Weiner, M Edelstein, and MM Oken
	JCO Feb 1 1993: 314–319. [Abstract] [PDF]
	Harvesting bone marrow in an outpatient setting using newer anesthetic agents
	AC Thorne, M Stewart, and SC Gulati
	JCO Feb 1 1993: 320–323. [Abstract] [PDF]
	Surgical salvage of chemorefractory germ cell tumors
	BR Murphy, ES Breeden, JP Donohue, J Messemer, W Walsh, BJ Roth, and LH Einhorn
	JCO Feb 1 1993: 324–329. [Abstract] [PDF]
	Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer
	N Kemeny, A Cohen, K Seiter, JA Conti, ER Sigurdson, Y Tao, D Niedzwiecki, J Botet, and A Budd
	JCO Feb 1 1993: 330–335. [Abstract] [PDF]
	Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group
	N Murray, P Coy, JL Pater, I Hodson, A Arnold, BC Zee, D Payne, EC Kostashuk, WK Evans, and P Dixon
	JCO Feb 1 1993: 336–344. [Abstract] [PDF]
	Multicenter phase II efficacy trial of toremifene in tamoxifen- refractory patients with advanced breast cancer
	CL Vogel, I Shemano, J Schoenfelder, RA Gams, and MR Green
	JCO Feb 1 1993: 345–350. [Abstract] [PDF]
	DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials
	TE Witzig, JN Ingle, DJ Schaid, LE Wold, JF Barlow, NJ Gonchoroff, JB Gerstner, JE Krook, CS Grant, and JA Katzmann
	JCO Feb 1 1993: 351–359. [Abstract] [PDF]
	Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis [published erratum appears in J Clin Oncol 1994 Mar;12(3):643]
	EE Vokes, MJ Ratain, R Mick, JM McEvilly, D Haraf, M Kozloff, V Hamasaki, RR Weichselbaum, WR Panje, and B Wenig
	JCO Feb 1 1993: 360–368. [Abstract] [PDF]
	Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy
	MB Hazuka, WD Burleson, DN Stroud, CE Leonard, KO Lillehei, and JJ Kinzie
	JCO Feb 1 1993: 369–373. [Abstract] [PDF]
	Bioavailability of low-dose oral etoposide
	KR Hande, MG Krozely, FA Greco, JD Hainsworth, and DH Johnson
	JCO Feb 1 1993: 374–377. [Abstract] [PDF]
	Goals of palliative cancer therapy
	F Porzsolt and I Tannock
	JCO Feb 1 1993: 378–381. [Abstract] [PDF]
Meta-analyses, use and misuse
M Buyse
JCO Feb 1 1993: 382a. [PDF]
More is not always better: a case for low-dose leucovorin
MM Borner and O Sartor
JCO Feb 1 1993: 382b–383. [PDF]
Warfarin and small-cell lung cancer
MH Huber and WK Hong
JCO Feb 1 1993: 383. [PDF]
A new complication of permanent indwelling central venous catheters using high-dose fluorouracil and leucovorin
B Ardalan and MR Flores
JCO Feb 1 1993: 384. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	A Randomized Comparison of Cisplatin Alone or in Combination With Methotrexate, Vinblastine, and Doxorubicin in Patients With Metastatic Urothelial Carcinoma: A Cooperative Group Study
	Patrick J. Loehrer, Sr, Lawrence H. Einhorn, Paul J. Elson, E. David Crawford, Philip Kuebler, Ian Tannock, Derek Raghavan, Robin Stuart-Harris, Michael F. Sarosdy, Bruce A. Lowe, Brent Blumenstein, and Donald Trump
	JCO Feb 1 1993: 384-a. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.